Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Presenter: Kendra Grubb

September 27, 2019

Presentation TCT 2019

Real-World Experience of the LOTUS Edge Valve

Presenter: Hemal Gada

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

ACURATE neo: Features and Benefits for Optimized TAVR

Presenter: Helge Möllmann

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Program Update: The ACURATE NEO TAVR System

Presenter: Michael Reardon

September 27, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

September 26, 2019

Advertisement

Predicting Final Valve Position After TAVR: Different Devices, Different Success

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Real-World Experience of the LOTUS Edge Valve

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

ACURATE neo: Features and Benefits for Optimized TAVR

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Program Update: The ACURATE NEO TAVR System

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content